diMARIE Study on Digital, Personalized Cancer Risk Assessment

Digital. Individual. Understandable.

Teilnehmer-Einschluss abgeschlossen, vielen Dank.
diMARIE

Who is behind the study?

The diMARIE study is being conducted at the University Hospital Würzburg. Oncosia Scientific provides the medical software OncoPrevia.

Berfin Sezen Cantepe

Medical Doctor
Berfin Sezen Cantepe

Study Physician
Anna Fleischer

Dr. med.
Anna Fleischer

Lead Study Physician
Imad Maatouk

Prof. Dr. med.
Imad Maatouk

Jenny Kolb

Jenny Kolb

Study Assistant

Why and for what? Our reasons and goals.

The early detection of cancer has been proven to improve chances of recovery and quality of life. In our study, we are testing a new digital solution for risk stratification based on medical S3 guidelines, combined with structured informational consultations. The goal is to derive individual recommendations for cancer prevention and early detection – directly at the general practitioner or specialist.

Making individual risk visible

Every person has a unique risk profile. With OncoPrevia, we raise awareness of personal risk factors – evidence-based, easy to understand, and scientifically grounded.

Building trust. Enabling prevention.

Clear and respectful communication creates confidence: With personalized recommendations and easy-to-understand reports, we promote participation in relevant early detection measures.

Easily integrated. Practical for everyday clinical use.

OncoPrevia adapts to everyday clinical routines – not the other way around. Without technical barriers, our software supports medical professionals in effectively implementing cancer prevention.

1. Your Participant ID – the first step

To ensure the secure processing of your data, you will receive a personal participant ID for the diMARIE study. You can request it directly through the web application or via this link: Get Participant-ID

With your ID and the password provided to you, you can easily log in to our web application OncoPrevia.

2. Digital Information & Consent

Immediately after logging in, you will receive all essential information about the study – clearly explained through video and informational material. If you agree, you can confirm your participation right away.

Still have questions? We’re here for you – via email, phone, or an online appointment. (Contact information below)

3. Digital questionnaires about your health

In the next step, you will answer questions about: general information, personal medical history, family history of cancer, and risk factors. Completing the questionnaires takes about 15–20 minutes and can be saved to finish later.

4. Evaluation & first consultation

About one week after completing your information, we will schedule an online or telephone consultation with you. Together, we will discuss your results and answer your questions.

Afterward, we will ask you to participate in a short scientific interview as part of the study.

5. Final consultation – after four weeks

Four weeks later, we would like to speak with you again. The goal is to better understand how you have processed the information and how we can further improve the communication.

Studienablauf
Studienablauf

Do you have questions about the study in advance?

Write to us or give us a call

+49 (0) 160 96255919

Send us a message on WhatsApp or call us directly

Book a free online consultation about the study

Hier buchen

Talk to one of our experts about your concerns and get initial information.

Send us an Email

mail@oncoprevia.de

We reply within 24 hours

Oncosia Scientific

Nuclear Medicine
& Dosimetry

Contact

Oncosia Scientific GmbH

mail@oncosia.de

+49 (0) 160 96255919

© 2025 Oncosia Scientific GmbH. All rights reserved